|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/10 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 35/00 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K 14/70521 | (2013.01) | ||
| C07K 14/70578 | (2013.01) | ||
| A61K 35/00 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K 14/725 | (2006.01) | ||
| C07K2319/03 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/2833 | (2013.01) | ||
| C12N 5/0783 | (2010.01) | ||
| A61K2039/507 | (2013.01) | ||
| C12Q 1/68 | (2018.01) | ||
| A61K2039/5156 | (2013.01) | ||
| A61K2039/5158 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/75 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/33 | (2013.01) | ||
| C12N 5/0636 | (2013.01) | ||
| C12N2510/00 | (2013.01) | ||
| A61K 38/00 | (2013.01) |
| (11) | Number of the document | 3519564 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17855171.9 |
| Date of filing the European patent application | 2017-09-28 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2017/051102 |
| Date | 2017-09-28 |
| (87) | Number | WO 2018/061012 |
| Date | 2018-04-05 |
| (30) | Number | Date | Country code |
| 201662400737 P | 2016-09-28 | US |
| (72) |
GROSS, Gideon , IL
BEIMAN, Merav , IL
GIBSON, William , US
DAHARY, Dvir , IL
|
| (73) |
Gavish-Galilee Bio Applications Ltd ,
P.O. Box 831, 1101602 Kiryat Shmona,
IL
|
| (54) | A UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER |
| A UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER |